These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25066473)

  • 1. Phosphatidylinositol binding of Saccharomyces cerevisiae Pdr16p represents an essential feature of this lipid transfer protein to provide protection against azole antifungals.
    Holič R; Simová Z; Ashlin T; Pevala V; Poloncová K; Tahotná D; Kutejová E; Cockcroft S; Griač P
    Biochim Biophys Acta; 2014 Oct; 1842(10):1483-90. PubMed ID: 25066473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The yeast Saccharomyces cerevisiae Pdr16p restricts changes in ergosterol biosynthesis caused by the presence of azole antifungals.
    Šimová Z; Poloncová K; Tahotná D; Holič R; Hapala I; Smith AR; White TC; Griač P
    Yeast; 2013 Jun; 30(6):229-41. PubMed ID: 23606207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yeast Sec14-like lipid transfer proteins Pdr16 and Pdr17 bind and transfer the ergosterol precursor lanosterol in addition to phosphatidylinositol.
    Šťastný D; Petrisková L; Tahotná D; Bauer J; Pokorná L; Holič R; Valachovič M; Pevala V; Cockcroft S; Griač P
    FEBS Lett; 2023 Feb; 597(4):504-514. PubMed ID: 36482167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast phosphatidylinositol transfer protein Pdr17 does not require high affinity phosphatidylinositol binding for its cellular function.
    Pevalová Z; Pevala V; Blunsom NJ; Tahotná D; Kotrasová V; Holič R; Pokorná L; Bauer JA; Kutejová E; Cockcroft S; Griač P
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1412-1421. PubMed ID: 31302248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDR16-mediated azole resistance in Candida albicans.
    Saidane S; Weber S; De Deken X; St-Germain G; Raymond M
    Mol Microbiol; 2006 Jun; 60(6):1546-62. PubMed ID: 16796687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDR16 and PDR17, two homologous genes of Saccharomyces cerevisiae, affect lipid biosynthesis and resistance to multiple drugs.
    van den Hazel HB; Pichler H; do Valle Matta MA; Leitner E; Goffeau A; Daum G
    J Biol Chem; 1999 Jan; 274(4):1934-41. PubMed ID: 9890948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Aspergillus fumigatus Damage Resistance Protein Family Coordinately Regulates Ergosterol Biosynthesis and Azole Susceptibility.
    Song J; Zhai P; Zhang Y; Zhang C; Sang H; Han G; Keller NP; Lu L
    mBio; 2016 Feb; 7(1):e01919-15. PubMed ID: 26908577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress response and expression of fluconazole resistance associated genes in the pathogenic yeast Candida glabrata deleted in the CgPDR16 gene.
    Culakova H; Dzugasova V; Valencikova R; Gbelska Y; Subik J
    Microbiol Res; 2015 May; 174():17-23. PubMed ID: 25946325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of PDR16 confers resistance to complex sphingolipid biosynthesis inhibitor aureobasidin A in yeast Saccharomyces cerevisiae.
    Katsuki Y; Yamaguchi Y; Tani M
    FEMS Microbiol Lett; 2018 Feb; 365(3):. PubMed ID: 29240942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signalling.
    Edlind T; Smith L; Henry K; Katiyar S; Nickels J
    Mol Microbiol; 2002 Oct; 46(1):257-68. PubMed ID: 12366848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Erg11 lanosterol 14-α-demethylase-Arv1 complex is required for Candida albicans virulence.
    Villasmil ML; Barbosa AD; Cunningham JL; Siniossoglou S; Nickels JT
    PLoS One; 2020; 15(7):e0235746. PubMed ID: 32678853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural determinants for phosphatidylinositol recognition by Sfh3 and substrate-induced dimer-monomer transition during lipid transfer cycles.
    Yang H; Tong J; Leonard TA; Im YJ
    FEBS Lett; 2013 Jun; 587(11):1610-6. PubMed ID: 23603387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs.
    Mount HO; Revie NM; Todd RT; Anstett K; Collins C; Costanzo M; Boone C; Robbins N; Selmecki A; Cowen LE
    PLoS Genet; 2018 Apr; 14(4):e1007319. PubMed ID: 29702647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimeric Sfh3 has structural changes in its binding pocket that are associated with a dimer-monomer state transformation induced by substrate binding.
    Yuan Y; Zhao W; Wang X; Gao Y; Niu L; Teng M
    Acta Crystallogr D Biol Crystallogr; 2013 Mar; 69(Pt 3):313-23. PubMed ID: 23519406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vacuolar Sequestration of Azoles, a Novel Strategy of Azole Antifungal Resistance Conserved across Pathogenic and Nonpathogenic Yeast.
    Khandelwal NK; Wasi M; Nair R; Gupta M; Kumar M; Mondal AK; Gaur NA; Prasad R
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective sterol C5-6 desaturation and azole resistance: a new hypothesis for the mode of action of azole antifungals.
    Watson PF; Rose ME; Ellis SW; England H; Kelly SL
    Biochem Biophys Res Commun; 1989 Nov; 164(3):1170-5. PubMed ID: 2556119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of the CgPDR16 gene attenuates azole tolerance and biofilm production in pathogenic Candida glabrata.
    Culakova H; Dzugasova V; Perzelova J; Gbelska Y; Subik J
    Yeast; 2013 Oct; 30(10):403-14. PubMed ID: 23939632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
    Keniya MV; Ruma YN; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modelling of lanosterol 14 alpha-demethylase (CYP51) from Saccharomyces cerevisiae via homology with CYP102, a unique bacterial cytochrome P450 isoform: quantitative structure-activity relationships (QSARs) within two related series of antifungal azole derivatives.
    Lewis DF; Wiseman A; Tarbit MH
    J Enzyme Inhib; 1999; 14(3):175-92. PubMed ID: 10445042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.